Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant?
Article in Expert Review of Anticancer Therapy (November 2022)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Long-term response of over ten years with sorafenib monotherapy in metastatic renal cell carcinoma: a case report
Article in Journal of Medical Case Reports (June 2016)
Molecular Markers of Kidney Cancer Progression, Association with Efficiency of Pazopanib Therapy
Article in Journal of Biomedical Science and Engineering (November 2015)